Literature DB >> 25102843

Is the pharmaceutical industry improving with regard to access to essential medicines?

Hans V Hogerzeil1, Jayasree K Iyer2, Lisanne Urlings2, Tara Prasad2, Sara Brewer2.   

Abstract

Mesh：

Substances：

Year:  2014        PMID： 25102843     DOI： 10.1016/S2214-109X(13)70159-1

Source DB:  PubMed          Journal:  Lancet Glob Health        ISSN： 2214-109X            Impact factor:   26.763


× No keyword cloud information.
  3 in total

Review 1.  Innovative Approaches to Increase Access to Medicines in Developing Countries.

Authors:  Hilde Stevens; Isabelle Huys
Journal:  Front Med (Lausanne)       Date:  2017-12-07

2.  Corporate social responsibility to improve access to medicines: the case of Brazil.

Authors:  Halla Thorsteinsdóttir; Natasha Ovtcharenko; Jillian Clare Kohler
Journal:  Global Health       Date:  2017-02-21       Impact factor: 4.185

3.  Challenges of access to medicine and the responsibility of pharmaceutical companies: a legal perspective.

Authors:  Saeed Ahmadiani; Shekoufeh Nikfar
Journal:  Daru       Date:  2016-05-04       Impact factor: 3.117
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.